Torrent Pharmaceuticals Ltd.
Snapshot View

1545.00 +4.30 ▲0.3%

03 February 2023, 04:01:00 PM
Volume: 871

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.torrentpharma.com
Market Cap 51,856.61 Cr.
Enterprise Value(EV) 55,959.82 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 24.55 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 62.92 Trailing Twelve Months Ending 2022-12
Industry PE 32.22 Trailing Twelve Months Ending 2022-12
Book Value / Share 188.34 Trailing Twelve Months Ending 2022-12
Price to Book Value 8.20 Calculated using Price: 1,545.00
Dividend Yield 1.57 Period Ending 2022-03
No. of Shares Subscribed 33.84 Cr. 338,445,440 Shares
FaceValue 5
Company Profile
Torrent Pharmaceuticals has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). With Unichem's domestic business acquisition, Torrent has entered the list of top pharma firms in the Indian Pharma Market (IPM) and is ranked No 8 in the IPM.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.28%
1 Week
+0.47%
1 Month
-0.11%
3 Month
-8.55%
6 Month
+2.04%
1 Year
+14.25%
2 Year
+15.64%
5 Year
+127.60%
10 Year
+791.72%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 39.94 34.19 57.92 23.80 15.12 9.34 21.47 23.49 13.18
Return on Capital Employed (%) 35.06 26.98 45.63 20.36 13.81 9.75 15.28 17.62 14.35
Return on Assets (%) 15.16 11.71 20.89 10.28 5.81 3.15 7.50 9.20 5.92

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 1,902 2,491 3,494 4,350 4,622 4,724 4,823 5,837 5,953 6,091
Non Curr. Liab. 927 2,505 1,995 2,303 4,142 3,861 3,299 2,924 2,238 2,657
Curr. Liab. 2,175 2,824 3,285 2,738 5,202 5,165 5,454 4,892 4,415 3,950
Minority Int. 0 0 0 0 1
Equity & Liab. 5,004 7,820 8,775 9,392 13,967 13,751 13,577 13,653 12,606 12,698
Non Curr. Assets 1,600 3,768 4,086 4,513 8,705 8,714 8,596 8,130 7,312 7,349
Curr. Assets 3,404 4,051 4,689 4,879 5,262 5,038 4,981 5,523 5,295 5,349
Misc. Exp. not W/O
Total Assets 5,004 7,820 8,775 9,392 13,967 13,751 13,577 13,653 12,606 12,698

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 4,185 4,653 6,667 5,816 5,950 7,673 7,939 8,005 8,508 9,260
Other Income 38 286 229 223 307 64 121 57 197 92
Total Income 4,223 4,939 6,896 6,039 6,257 7,736 8,061 8,061 8,705 9,352
Total Expenditure -3,233 -3,633 -3,937 -4,438 -4,609 -5,696 -5,769 -5,524 -6,077 -6,584
PBIDT 990 1,306 2,959 1,601 1,648 2,040 2,292 2,537 2,628 2,768
Interest -59 -175 -184 -206 -308 -504 -451 -353 -255 -283
Depreciation -87 -191 -238 -307 -409 -618 -654 -658 -662 -673
Taxation -180 -189 -610 -155 -253 -125 -162 -274 -449 -496
Exceptional Items -194 -357 -485 -485
PAT 664 751 1,733 934 678 436 1,025 1,252 777 831
Minority Interest 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 664 751 1,733 934 678 436 1,025 1,252 777 831
Adjusted EPS 20 22 51 28 20 13 30 37 23 25

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 153 599 810 2,742 1,009 894 1,798 1,393 2,005 1,803
Cash Fr. Inv. -242 -356 -2,162 -838 -787 -4,707 -241 199 -449 -197
Cash Fr. Finan. 20 86 1,212 -1,435 -193 3,417 -1,314 -1,549 -1,651 -1,781
Net Change -68 330 -140 469 29 -395 242 42 -95 -175
Cash & Cash Eqvt 687 955 865 1,050 1,068 702 940 662 573 398

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25
Public 28.75 28.75 28.75 28.75 28.75 28.75 28.75 28.75 28.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 03 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates
Wed, 01 Feb 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and nine months ended 31st December 2022
Fri, 27 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates

Technical Scans View Details >>

Fri, 03 Feb 2023
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 5 Years High Increase in 5 Years
Thu, 02 Feb 2023
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 5 Years High Increase in 5 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 246,567.66 1,027.65 +2.0%
Cipla Ltd. 82,812.97 1,026.00 +0.1%
Divi's Laboratories Ltd. 76,573.08 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. 72,577.66 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. 61,039.46 4,245.20 +0.3%
Abbott India Ltd. 44,198.55 20,800.00 +1.5%
Zydus Lifesciences Ltd. 44,030.88 435.00 +0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.54 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 31.39 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 25.59 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.92 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.70 4,245.20 +0.3%
Abbott India Ltd. Standalone 2022-09 50.12 20,800.00 +1.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 22.71 435.00 +0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.46 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 3.65 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 6.31 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.20 4,245.20 +0.3%
Abbott India Ltd. Standalone 2022-09 16.28 20,800.00 +1.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 2.64 435.00 +0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,245.20 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 20,800.00 +1.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 435.00 +0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 435.00 +0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 435.00 +0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,245.20 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,800.00 +1.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 435.00 +0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,245.20 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 20,800.00 +1.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 435.00 +0.6%

FAQ's On Torrent Pharmaceuticals Ltd.

What is Torrent Pharma share price?

Can I buy Torrent Pharma shares now?

What is the Dividend Yield of Torrent Pharma?

What is the Market Cap of Torrent Pharma?

What are the key metrics to analyse Torrent Pharma?

What is the 52 Week High and Low of Torrent Pharma?

What is the trend of Torrent Pharma share price?